Heteroaryl compounds as kinase inhibitors

Details for Australian Patent Application No. 2010291212 (hide)

Owner Novartis AG

Inventors Pfister, Keith B.; Sendzik, Martin

Agent Davies Collison Cave

Pub. Number AU-A-2010291212

PCT Pub. Number WO2011/026917

Priority 61/275,939 04.09.09 US

Filing date 2 September 2010

Wipo publication date 10 March 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

23 February 2012 PCT application entered the National Phase

  PCT publication WO2011/026917 Priority application(s): WO2011/026917

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010291215-Bis-benzimidazole derivatives

2010291209-Activation of electrode surfaces by means of vacuum deposition techniques in a continuous process